From Grants to Growth: Future-Proofing Client Funding in 2026

Why It Matters

As the UK tightens R&D rules while offering a more integrated suite of incentives, advisers who can orchestrate these tools will give clients a decisive competitive edge and safeguard cash‑flow. Mastering this strategic approach is crucial for firms aiming to accelerate innovation, secure patient capital, and contribute to the nation’s broader growth agenda in 2026.

Summary

In this episode Kelly Oakley, Associate Director of Incentives and Reliefs at ForrestBrown, explains how advisers can move from transactional grant claims to holistic, lifecycle funding strategies for 2026. She highlights the newly stable yet complex R&D tax landscape, the importance of aligning with the government's eight priority sectors, and the need for rapid, bid‑ready preparation for short grant windows. Oakley outlines how to sequence incentives—R&D tax relief, grants, innovation loans, and Patent Box—according to a client’s development stage, and stresses the value of audit‑ready record‑keeping and cash‑flow forecasting to future‑proof funding plans.